Judith Trotman Selected Research

Spasm (Spasms)

11/2023	Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.
10/2020	A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Judith Trotman Research Topics

Disease

27	Neoplasms (Cancer) 03/2024 - 09/2010
21	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2023 - 08/2011
19	Lymphoma (Lymphomas) 11/2023 - 09/2010
13	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2024 - 01/2018
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 01/2017
8	Infections 04/2024 - 01/2017
6	Atrial Fibrillation 11/2023 - 06/2018
5	COVID-19 12/2023 - 01/2020
5	Neutropenia 11/2023 - 01/2017
5	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 05/2015
5	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021 - 08/2011
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2024 - 10/2019
4	Hypertension (High Blood Pressure) 11/2023 - 06/2018
4	Diarrhea 11/2023 - 06/2018
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 09/2010
3	Pneumonia (Pneumonitis) 11/2023 - 10/2020
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 01/2017
3	Multiple Myeloma 12/2022 - 05/2010
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 01/2019
2	Agammaglobulinemia (Hypogammaglobulinemia) 04/2024 - 03/2024
2	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 03/2024
2	Spasm (Spasms) 11/2023 - 10/2020
2	Disease Progression 01/2023 - 01/2022
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2022
2	Mycosis Fungoides 12/2021 - 01/2021
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 12/2021 - 01/2017
2	Edema (Dropsy) 01/2021 - 10/2020
2	Hemorrhage 12/2020 - 10/2020
2	Anemia 10/2019 - 02/2017
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2024
1	Communicable Diseases (Infectious Diseases) 12/2023
1	Residual Neoplasm 12/2023
1	Immunoglobulin Light-chain Amyloidosis 01/2023
1	Hairy Cell Leukemia 01/2023
1	Circulating Neoplastic Cells 01/2023
1	Fever (Fevers) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 12/2021
1	Pruritus (Itching) 12/2021
1	Pain (Aches) 12/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021
1	Contusions 10/2020
1	Fatigue 01/2020

Drug/Important Bio-Agent (IBA)

21	Rituximab (Mabthera)FDA Link 03/2024 - 10/2014
17	zanubrutinibIBA 02/2024 - 01/2018
14	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 10/2018
13	ibrutinibIBA 02/2024 - 06/2018
8	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 06/2016
8	GalliumIBA 12/2023 - 10/2018
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 01/2017
7	obinutuzumabIBA 11/2023 - 10/2018
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2023 - 09/2010
7	Lenalidomide (CC 5013)FDA Link 09/2023 - 01/2017
6	Vincristine (Oncovin)FDA LinkGeneric 02/2024 - 08/2017
6	Prednisone (Sone)FDA LinkGeneric 02/2024 - 01/2017
6	Bendamustine Hydrochloride FDA Link 09/2023 - 10/2018
4	Brentuximab VedotinIBA 02/2024 - 01/2017
4	Melphalan (Alkeran)FDA LinkGeneric 12/2022 - 05/2010
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2018
3	tafasitamabIBA 09/2023 - 01/2022
3	Immunoglobulin M (IgM)IBA 01/2023 - 01/2017
2	Immunoglobulin G (IgG)IBA 04/2024 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 04/2024 - 03/2024
2	romidepsin (FK228)FDA Link 02/2024 - 01/2022
2	polatuzumab vedotinIBA 09/2023 - 07/2023
2	ParaproteinsIBA 01/2023 - 01/2017
2	Histone Deacetylase InhibitorsIBA 01/2022 - 10/2020
2	Methotrexate (Mexate)FDA LinkGeneric 12/2021 - 05/2015
2	Prednisolone (Predate)FDA LinkGeneric 01/2019 - 05/2015
1	VaccinesIBA 12/2023
1	Antiviral Agents (Antivirals)IBA 12/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	cold agglutininsIBA 01/2023
1	6-bromo-2-naphthyl sulfate (BNS)IBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	AntigensIBA 01/2023
1	CryoglobulinsIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2023
1	Complement System Proteins (Complement)IBA 11/2022
1	Circulating Tumor DNAIBA 11/2022
1	Bexarotene (LGD1069)FDA Link 12/2021
1	COVID-19 VaccinesIBA 01/2021
1	10-propargyl-10-deazaaminopterin FDA Link 01/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 12/2020

Therapy/Procedure

37	Therapeutics 12/2023 - 05/2010
6	Drug Therapy (Chemotherapy) 02/2024 - 10/2014
3	Induction Chemotherapy 01/2021 - 01/2020
2	Aftercare (After-Treatment) 03/2023 - 01/2018
1	Antibiotic Prophylaxis 04/2024
1	Time-to-Treatment 12/2023
1	Critical Care (Surgical Intensive Care) 12/2023
1	Transplantation 01/2023
1	Salvage Therapy 01/2023
1	Cell Transplantation 01/2023
1	Precision Medicine 11/2022
1	Drug Tapering 01/2022